|
HEATR2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.56510999999027E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.55957999999901E-05 |
| Normal-vs-Stage2 |
1.873790E-01 |
| Normal-vs-Stage3 |
3.95109999999921E-05 |
| Normal-vs-Stage4 |
1.539880E-02 |
| Stage1-vs-Stage2 |
7.042500E-02 |
| Stage1-vs-Stage3 |
6.620200E-01 |
| Stage1-vs-Stage4 |
4.394200E-01 |
| Stage2-vs-Stage3 |
5.215600E-02 |
| Stage2-vs-Stage4 |
3.846000E-01 |
| Stage3-vs-Stage4 |
3.352600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73232999999273E-05 |
| Normal-vs-AfricanAmerican |
5.009800E-02 |
| Normal-vs-Asian |
1.019760E-04 |
| Caucasian-vs-AfricanAmerican |
3.935800E-01 |
| Caucasian-vs-Asian |
9.338400E-01 |
| AfricanAmerican-vs-Asian |
2.476600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.409150E-04 |
| Normal-vs-Female |
2.04639999999978E-05 |
| Male-vs-Female |
8.362000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.48699999985769E-07 |
| Normal-vs-Age(41-60Yrs) |
8.10320000000919E-05 |
| Normal-vs-Age(61-80Yrs) |
1.762010E-02 |
| Normal-vs-Age(81-100Yrs) |
2.724000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.588600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.190300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.873600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.678800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.301800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.386000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.476000E-01 |
| Classical-VS-Follicular |
8.146200E-01 |
| Classical-VS-Other |
6.022400E-01 |
| Classical-VS-Normal |
2.191900E-04 |
| Tall-VS-Follicular |
6.370400E-01 |
| Tall-VS-Other |
5.123600E-01 |
| Tall-VS-Normal |
3.371600E-02 |
| Follicular-VS-Other |
7.464200E-01 |
| Follicular-VS-Normal |
1.956340E-03 |
| Other-VS-Normal |
4.220100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.7477000000008E-06 |
| Normal-vs-N1 |
5.579200E-04 |
| N0-vs-N1 |
6.688800E-01 |
|
|
